Petra Zieglmayer

2.3k total citations
54 papers, 1.1k citations indexed

About

Petra Zieglmayer is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Petra Zieglmayer has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Immunology and Allergy, 37 papers in Physiology and 22 papers in Dermatology. Recurrent topics in Petra Zieglmayer's work include Allergic Rhinitis and Sensitization (53 papers), Asthma and respiratory diseases (37 papers) and Food Allergy and Anaphylaxis Research (18 papers). Petra Zieglmayer is often cited by papers focused on Allergic Rhinitis and Sensitization (53 papers), Asthma and respiratory diseases (37 papers) and Food Allergy and Anaphylaxis Research (18 papers). Petra Zieglmayer collaborates with scholars based in Austria, Germany and United Kingdom. Petra Zieglmayer's co-authors include René Zieglmayer, Friedrich Horak, Patrick Lemell, Rudolf Valenta, Philippe Moingeon, Laurence Van Overtvelt, A. Montagut, Sylvie Galvain, David I. Bernstein and Hendrik Nolte and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Petra Zieglmayer

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petra Zieglmayer Austria	19	937	813	396	126	91	54	1.1k
R. Fadel France	14	859 0.9×	841 1.0×	431 1.1×	188 1.5×	35 0.4×	27	1.0k
David F. Graft United States	16	955 1.0×	378 0.5×	288 0.7×	207 1.6×	52 0.6×	40	1.2k
Morgan Andersson Sweden	18	336 0.4×	491 0.6×	88 0.2×	241 1.9×	51 0.6×	39	734
Frank C. Hampel United States	24	1.4k 1.5×	1.4k 1.7×	229 0.6×	540 4.3×	423 4.6×	72	1.7k
S. Isola Italy	12	393 0.4×	356 0.4×	266 0.7×	86 0.7×	12 0.1×	35	594
Simon P. Lee United Kingdom	7	837 0.9×	413 0.5×	987 2.5×	41 0.3×	8 0.1×	7	1.2k
Alessia Marseglia Italy	16	348 0.4×	546 0.7×	113 0.3×	342 2.7×	11 0.1×	22	780
Elena Crestani United States	13	385 0.4×	344 0.4×	98 0.2×	114 0.9×	19 0.2×	26	909
Charles F. Schuler United States	12	224 0.2×	178 0.2×	189 0.5×	70 0.6×	15 0.2×	35	628
S. Echechipía Spain	16	568 0.6×	360 0.4×	438 1.1×	73 0.6×	6 0.1×	39	978

Countries citing papers authored by Petra Zieglmayer

Since Specialization

Citations

This map shows the geographic impact of Petra Zieglmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Zieglmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Zieglmayer more than expected).

Fields of papers citing papers by Petra Zieglmayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Zieglmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Zieglmayer. The network helps show where Petra Zieglmayer may publish in the future.

Co-authorship network of co-authors of Petra Zieglmayer

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Zieglmayer. A scholar is included among the top collaborators of Petra Zieglmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Zieglmayer. Petra Zieglmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zielen, Stefan, Hartmut Richter, Petra Zieglmayer, et al.. (2025). Long-term impact of a birch/alder/hazel or birch-only liquid sublingual immunotherapy on birch-family pollen respiratory allergy: A real-world study. Allergology International. 74(4). 572–578.

Morokutti-Kurz, Martina, Petra Zieglmayer, Christiane Koller, et al.. (2024). Decongestant Effect of “Coldamaris Akut”, a Carrageenan- and Sorbitol-Containing Nasal Spray in Seasonal Allergic Rhinitis. International Journal of General Medicine. Volume 17. 5105–5121.

Kappen, Jasper H., Zuzana Diamant, Ioana Agache, et al.. (2023). Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper. Allergy. 78(11). 2835–2850. 15 indexed citations

Zieglmayer, Petra & Oliver Pfaar. (2022). Update on the use of allergen challenge chambers in immunotherapy: clinical implications.. PubMed. 22(2). 132–136. 5 indexed citations

Mittermann, Irene, et al.. (2022). IgE reactivity patterns in Asian and central European cockroach-sensitized patients reveal differences in primary sensitizing allergen sources. Journal of Allergy and Clinical Immunology Global. 1(3). 145–153. 4 indexed citations

Becker, Sven, Petra Zieglmayer, Gabriela Cantó, et al.. (2021). A meta‐analysis on allergen‐specific immunotherapy using MCT^® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis. Clinical and Translational Allergy. 11(4). e12037–e12037. 13 indexed citations

Canonica, Giorgio Walter, Ludger Klimek, Sarah Acaster, et al.. (2021). Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey. Current Medical Research and Opinion. 37(7). 1259–1272. 2 indexed citations

Lupinek, Christian, Susanne Vrtala, Huey‐Jy Huang, et al.. (2020). Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus: A Possible Biomarker for Allergic Asthma. Allergy Asthma and Immunology Research. 13(1). 154–154. 12 indexed citations

Tulaeva, Inna, Carolin Cornelius, Petra Zieglmayer, et al.. (2020). Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32. EBioMedicine. 59. 102953–102953. 11 indexed citations

10.

Pfaar, Oliver & Petra Zieglmayer. (2020). Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy. Clinical and Translational Allergy. 10(1). 33–33. 18 indexed citations

11.

Zieglmayer, Petra, Hendrik Nolte, Harold S. Nelson, et al.. (2016). Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period. Journal of Allergy and Clinical Immunology. 137(2). AB62–AB62. 1 indexed citations

12.

Cornelius, Carolin, Katrin Schöneweis, Fanny Georgi, et al.. (2016). Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection. EBioMedicine. 11. 58–67. 38 indexed citations

13.

Horak, Friedrich, Kamal D. Puri, Bart Steiner, et al.. (2016). Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology. 137(6). 1733–1741. 27 indexed citations

14.

James, Louisa K., Mohamed H. Shamji, K. Blatt, et al.. (2015). Epitope specificity determines cross‐protection of a SIT‐induced IgG₄ antibody. Allergy. 71(1). 36–46. 17 indexed citations

15.

Egger, Cornelia, Christian Lupinek, Robin Ristl, et al.. (2015). Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure. PLoS ONE. 10(2). e0114991–e0114991. 12 indexed citations

16.

Zieglmayer, Petra. (2013). Are results of environmental exposure units transferable to real-life exposure?. Current Opinion in Allergy and Clinical Immunology. 13(3). 244–248. 13 indexed citations

17.

Bareille, Philippe, Robert Murdoch, Jane Denyer, et al.. (2013). The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis. International Journal of Clinical Pharmacology and Therapeutics. 51(7). 576–584. 34 indexed citations

18.

Overtvelt, Laurence Van, Véronique Baron‐Bodo, S. Horiot, et al.. (2011). Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy. 66(12). 1530–1537. 49 indexed citations

19.

Horak, Friedrich, Petra Zieglmayer, René Zieglmayer, et al.. (2009). Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. Journal of Allergy and Clinical Immunology. 124(3). 471–477.e1. 143 indexed citations

20.

Horak, Friedrich, Petra Zieglmayer, René Zieglmayer, Alexander Kavina, & Patrick Lemell. (2005). Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. British Journal of Clinical Pharmacology. 60(1). 24–31. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact